Lo Scalpello - Journal
https://www.loscalpellojournal.com/
<div class="section "> <div> <h2>Cos’è Lorem Ipsum?</h2> <p><strong>Lorem Ipsum</strong> è un testo segnaposto utilizzato nel settore della tipografia e della stampa. Lorem Ipsum è considerato il testo segnaposto standard sin dal sedicesimo secolo, quando un anonimo tipografo prese una cassetta di caratteri e li assemblò per preparare un testo campione. È sopravvissuto non solo a più di cinque secoli, ma anche al passaggio alla videoimpaginazione, pervenendoci sostanzialmente inalterato. Fu reso popolare, negli anni ’60, con la diffusione dei fogli di caratteri trasferibili “Letraset”, che contenevano passaggi del Lorem Ipsum, e più recentemente da software di impaginazione come Aldus PageMaker, che includeva versioni del Lorem Ipsum.</p> </div> </div>
Pacini Editore s.r.l.
en-US
Lo Scalpello - Journal
0390-5276
<p><strong>AUTHORSHIP STATEMENT FORM</strong><br><strong>The corresponding author must sign the <a title="AUTHORSHIP STATEMENT FORM" href="/libraryFiles/downloadPublic/5" target="_blank" rel="noopener">Authorship Statement Form</a>, save it in .pdf and return it by uploading at our submission platform http://www.loscalpellojournal.com/.</strong></p> <p><strong>It is the policy of the Journal to correspond exclusively with one designated corresponding author. As the corresponding author, it is your responsibility to communicate with your co-authors.</strong></p> <p><strong>AUTHORSHIP RESPONSIBILITY</strong></p> <p>(1) All authors participated sufficiently in the intellectual content, analysis of data (if applicable) and writing of the article, by the criteria for authorship by the International Committee of Medical Journal Editors (http://www.icmje.org/). (2) The corresponding author certifies that the definitive version of the manuscript has been approved by all co-authors, as well as, director of the Institute or Department where the work has been carried out. (3) All persons who have made substantial contributions to the work reported in this manuscript (e.g., data collection, writing or editing assistance) but who do not fulfill the authorship criteria are named along with their specific contributions as an acknowledgement in the manuscript. The corresponding author certifies that all persons named in the acknowledgement section have provided written permission to be named. (4) All authors have reviewed the final version of the article and approve it for publication. (5) Authors must state that the article submitted has previously published, and is not under consideration or accepted for publication (in whole or in part) elsewhere nor have assigned any right or interest in the article to any third party. (6) Written permission from the authors to reproduce any material copyright elsewhere has been obtained prior to submission. (7) Authors must specify that consent has been obtained from taking part in the investigations or, in the case of paediatric patients, from the guardian/s and that they have obtained written releases from patients whose names or photographs are submitted as part of the article. (8) For reports containing original corresponding author should have full access to all the data in the study and takes responsibility for the integrity of the data accuracy of data analysis. (9) Any manuscript concerned with human subjects, medical records, or human tissue that is submitted “Lo Scalpello Journal” should comply with the principles stated in the Declaration of Helsinki “Ethical Principles Medical Research Involving ‘Human Subjects”, adopted by the 18 World Medical Assembly, Helsinki, Finland, June 1964, amended most recently by the 64 World Medical Assembly, Fontaleza, Brazil, October 2013. If the study involves human subjects or records of human patients ethical approval MUST have been obtained. The corresponding author must state ethical approval was given, by whom and the relevant Judgementʼs reference number. The manuscript should contain a statement that the work has been approved by the appropriate Ethical Committee related to the institution(s) in which the work was and that subjects gave informed consent to the work. “Lo Scalpello Journal” requires institutional Ethics Committee approval for all human studies. For retrospective studies on patientsʼ records either a statement of approval or a statement exemption from the Committee is required. <strong>Ref N° of the Ethical Committee Approval must be indicated in the <a title="AUTHORSHIP STATEMENT FORM" href="/libraryFiles/downloadPublic/5" target="_blank" rel="noopener">Authorship Statement Form</a>. The study was approved by the Institutional Ethical Committee (the Name of the Institution must indicated in the <a title="AUTHORSHIP STATEMENT FORM" href="/libraryFiles/downloadPublic/5" target="_blank" rel="noopener">Authorship Statement Form</a>) and this is clearly stated in the Methods section of the article.</strong> This statement should also be provided upon submission of the manuscript. Studies involving experiments with animals must state that their was in accordance with institution guidelines and relevant national laws. (10) The article contains no libelous or unlawful statements,<br>does not infringe the privacy of others, or contains material or instructions that might cause harm or injury. The corresponding author shall indemnify and hold the Editors and its agents and licensees harmless from any damages, costs, and expenses reasonable attorneyʼs fees and costs of settlement) resulting by reason of any claim, action, or proceeding finally sustained settled inconsistent with the foregoing warranties and representations. (11) All manuscripts are screened for plagiarism, which<br>implies immediate rejection. Suspected plagiarism is handled in accordance with the COPE flowcharts (http://publicationethics.org/resources/flowcharts).<br>Every author or co-author of any article published in this Journal is solely responsible for the contents of the article, for the statement made in their paper and for the material sent. Every author or co-author needs to fully comply with the Regulation 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General Data Protection Regulation): “<em>Article 9. Processing of personal data revealing racial or ethnic origin, political opinions, religious or philosophical beliefs, or trade union membership, and the processing of genetic data, biometric data for the purpose of uniquely identifying natural person, data concerning health or data concerning a natural person's sex life or sexual orientation shall be prohibited</em>”.</p> <p><strong>PRIVACY POLICY STATEMENT.</strong> Personal data of the author will be managed by the Publisher in full compliance with the legislation on the privacy protection (art. 13 of EU regulation 2016/6799). According to articles 15-20 of the GDPR, any author may exercise specific rights, including the right to obtain access to personal data in an intelligible form, correct, update or them. Authors will also have the right to obtain from the Publisher limitation of data processing, and may also oppose to data processing legitimate reasons. In the case that the author believes that processing of his/her own personal data infringes GDPR regulation, he/she has the right to make a complaint to the Supervisory Authority for the Protection of Personal Data to art. 77 of the GDPR. Controller of data processing, according to art. 4.1.7 of the GDPR, is Mrs. Donatella Paoletti for Pacini Srl, with registered office in 56121 Pisa, Italy, Via A Gherardesca n. 1. To exercise the rights of GDPR referred to in paragraph same article, you can address any request for information to the following e-mail: privacy@pacinieditore.it. For further information refer to the website: <a href="https://www.loscalpellojournal.com/privacy-policy" target="_blank" rel="noopener">https://www.loscalpellojournal.com/privacy-policy</a></p> <p><strong>FINANCIAL DISCLOSURE</strong>. All authors must state any information that may be perceived as potential conflict of interest. must disclose all their affiliations including any relevant personal or institutional financial involvement (employment by an concern, consultancies, honoraria, speakers bureau, stock ownership or options, expert testimony, grants received or pending, membership on a standing advisory council or committee, a seat on the board of directors, or being publicly associated with company or its products, royalties, donation of medical equipment, etc.) with any organization that to any authorʼs knowledge direct interest, particularly a financial interest, in the subject matter or materials discussed. This declaration will be treated Editor as confidential while the paper is under review, and will not be made known to Reviewers. Please indicate on the <a title="AUTHORSHIP STATEMENT FORM" href="/libraryFiles/downloadPublic/5" target="_blank" rel="noopener"><strong>Authorship Statement Form</strong></a> whether or not you have or may have such a conflict of interest regarding the content of this article and nature of it.</p> <p><strong>COPYRIGHT TRANSFER AGREEMENT</strong>. (a) Authors assign to “Lo Scalpello Journal”, all copyright in and to including but not limited to the right to publish, republish, transmit, sell, distribute and otherwise use the article in whole or electronic and print editions of the Journal and in derivative works throughout the world, in all languages and in all media expression now known or later developed, and to license or permit others to do so. (b) The authors retain all proprietary rights, than copyright, such as patent rights. The authors retain the right to reuse any portion of the work, without charge, in personal compilations or other publications consisting solely of the author(sʼ) own works, including the author(sʼ) personal web home and to make copies of all or part of the Work for the author(sʼ) use for lecture or classroom purposes. The corresponding declares that any person named as co-author of the article is aware of the submission and has agreed to being so named. corresponding author accepts responsibility for releasing this material on behalf of any and all co-authors. The corresponding declares that statements and opinions given in the article are the expression of the authors. Responsibility for the content article rests upon the authors.</p>
-
Clinical and radiographical outcomes of the K-MOD PS total knee prosthesis: a retrospective analysis of 178 cases
https://www.loscalpellojournal.com/article/view/341
<p class="western" lang="en-US" align="left"><strong>Introduction</strong>. The demand for primary total knee prosthesis is growing globally with an annual rate ranging from 5% to 17%, representing the most valid solution in patients with advanced osteoarthritis, providing significant pain relief and an overall improvement in quality of life. Over the years, the evolution of knee prosthetic surgery has led to the development of numerous types of implants, different in materials in design philosophies and surgical approach, with the aim of ensuring the improvement of joint functionality, duration and better adaptation to the patient. The differences concern, for example, the degree of constraint, whether or not the posterior cruciate ligament is preserved and the type of osteointegration. Among the various proposals, PS prostheses are still the most used alternative, based on the “cam-post” system, guaranteeing an improvement of the ROM and a femoral rollback. <br><strong>Objectives</strong>. The aim of this study is to report the clinical and radiographic results of the Biompianti K-MOD PS total knee prosthesis. <br><strong>Materials and methods</strong>. 190 prosthesis implanted between September 2019 and January 2024 were evaluated in 181 patients. The outcome was evaluated through the presence of painful symptomatology, ROM and radiographic aspect, evaluating the presence of possible complications such as mobilization and infection.<br><strong>Results</strong>. Among the 190 implants, 178 were considered for follow up. The 178 prostheses were analyzed retrospectively with an average follow-up of 2.7 years (minimum 7 months, maximum 5 years, SD 1.3). The 88.8% obtained an improvement of the painful symptomatology and a satisfactory final ROM with no signs of mobilization at the radiographic control. 11.2% had complications, including the persistence of painful symptoms with ROM limitation (75%) and aseptic mobilization in 2 cases (10%); a single case of infection and one case of instability to varo-valgus stress were documented.<br><strong>Conclusions</strong>. This study showed an excellent outcome in terms of improved painful symptoms and ROM recovery associated with a low incidence of complications.</p>
Marica Vinci
Andrea Dorigotti
Renato Galli
Filippo Bellini
Mauro Porta
Copyright (c) 2025 © Ortopedici Traumatologi Ospedalieri d’Italia (O.T.O.D.i.)
https://creativecommons.org/licenses/by-nc-nd/4.0
2025-12-16
2025-12-16
39
67
70
10.36149/0390-5276-341
-
Pink pulseless hand in adults: a case report and literature review
https://www.loscalpellojournal.com/article/view/327
<p>Supracondylar fractures are among the most common traumatic fractures observed in children.<br>In the literature, the incidence reported in adult patients is relatively rare. Even rarer is vascular compromise at this level in adults. We present a case of closed distal humerus fracture with pink pulseless hand.</p>
Fabrizio Pannucci
Marco Baglioni
Leonardo Rodio
Luca Turelli
Copyright (c) 2025 © Ortopedici Traumatologi Ospedalieri d’Italia (O.T.O.D.i.)
https://creativecommons.org/licenses/by-nc-nd/4.0
2025-12-31
2025-12-31
39
71
75
10.36149/0390-5276-327
-
Wrist arthrodesis can provide strong grip strength and stable function after distal radius GCT resection, but at the cost of wrist motion
https://www.loscalpellojournal.com/article/view/348
<p>Wrist arthrodesis is a well-established and widely used reconstructive strategy following resection of a giant cell tumor (GCT) of the distal radius, particularly for aggressive or recurrent lesions. This literature review explored the functional outcomes and stability associated with this procedure. <br>The research, which included the analysis of 50 relevant studies, consistently demonstrated that arthrodesis provides reliable oncological control and effectively restores grip strength (generally 65-74% of the contralateral side) and mechanical stability. Despite the complete sacrifice of wrist flexion and extension, most patients maintain adequate forearm rotation, which allows them to perform the majority of daily activities.<br>The reported functional scores are generally excellent (MSTS scores ranging from 22 to 29), and DASH and PRWE scores indicate minimal disability and high patient satisfaction.<br>Arthrodesis is often preferred in patients with high functional demands or those engaged in heavy manual labor.<br>The main disadvantage is the permanent loss of motion, but this limitation is compensated by durable stability and the absence of pain. In conclusion, wrist arthrodesis is an effective and reliable solution for functional restoration, balancing oncological safety with robust hand function. The final choice of reconstruction must be personalized based on the tumor grade and the patient’s needs.</p>
Lorenzo Fiore
Michele Boffano
Ugo Albertini
Chiara Beltramo
Elena Boux
Andrea Ferro
Stefano Marone
Pietro Pellegrino
Nicola Ratto
Martina Rezzoagli
Raimondo Piana
Copyright (c) 2025 © Ortopedici Traumatologi Ospedalieri d’Italia (O.T.O.D.i.)
https://creativecommons.org/licenses/by-nc-nd/4.0
2025-12-31
2025-12-31
39
76
81
10.36149/0390-5276-348